BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22068052)

  • 1. An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.
    Vigneron AM; Vousden KH
    EMBO J; 2012 Jan; 31(2):471-80. PubMed ID: 22068052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.
    Vigneron AM; Ludwig RL; Vousden KH
    Genes Dev; 2010 Nov; 24(21):2430-9. PubMed ID: 21041411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
    Aylon Y; Ofir-Rosenfeld Y; Yabuta N; Lapi E; Nojima H; Lu X; Oren M
    Genes Dev; 2010 Nov; 24(21):2420-9. PubMed ID: 21041410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASPP1 and ASPP2: common activators of p53 family members.
    Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
    Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73.
    Kawahara M; Hori T; Chonabayashi K; Oka T; Sudol M; Uchiyama T
    Blood; 2008 Nov; 112(9):3856-66. PubMed ID: 18565851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
    Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
    Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
    Wang Y; Godin-Heymann N; Dan Wang X; Bergamaschi D; Llanos S; Lu X
    Cell Death Differ; 2013 Apr; 20(4):525-34. PubMed ID: 23392125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells.
    Dar AA; Belkhiri A; Ecsedy J; Zaika A; El-Rifai W
    Cancer Res; 2008 Nov; 68(21):8998-9004. PubMed ID: 18974145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
    Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
    DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo.
    Wilson AM; Morquette B; Abdouh M; Unsain N; Barker PA; Feinstein E; Bernier G; Di Polo A
    J Neurosci; 2013 Jan; 33(5):2205-16. PubMed ID: 23365256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG1 attenuates drug-induced cellular senescence.
    Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
    PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells.
    Heiss EH; Schilder YDC; Dirsch VM
    J Biol Chem; 2007 Sep; 282(37):26759-26766. PubMed ID: 17626009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
    de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
    J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.